Rhoshan Pharmaceuticals

• Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects

  Phase 1, Completed, 40 people, 7 Jan 2026

• NCT05166096

  Phase 1, Completed, 24 people, 21 Dec 2021

Sources: clinicaltrials.gov